GW9662 5 mg | 99.94%
TargetMol
GW9662 (TIMTEC-BB SBB006523) is a specific PPARγ antagonist (IC50: 3.3 nM, in a cell-free assay), with 100 to 1000-fold functional selectivity for PPARγ than PPARα/δ in cells.
More Information Supplier Page
GW9662 (TIMTEC-BB SBB006523) is a specific PPARγ antagonist (IC50: 3.3 nM, in a cell-free assay), with 100 to 1000-fold functional selectivity for PPARγ than PPARα/δ in cells.
More Information Supplier Page
GW9662 (TIMTEC-BB SBB006523) is a specific PPARγ antagonist (IC50: 3.3 nM, in a cell-free assay), with 100 to 1000-fold functional selectivity for PPARγ than PPARα/δ in cells.
More Information Supplier Page
GW9662 (TIMTEC-BB SBB006523) is a specific PPARγ antagonist (IC50: 3.3 nM, in a cell-free assay), with 100 to 1000-fold functional selectivity for PPARγ than PPARα/δ in cells.
More Information Supplier Page
GW9662 (TIMTEC-BB SBB006523) is a specific PPARγ antagonist (IC50: 3.3 nM, in a cell-free assay), with 100 to 1000-fold functional selectivity for PPARγ than PPARα/δ in cells.
More Information Supplier Page
CNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor.
More Information Supplier Page
CNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor.
More Information Supplier Page
LCL161, a SMAC mimetic, effectivity binds to and inhibits multiple IAPs (i.e. XIAP, c-IAP).
More Information Supplier Page
LCL161, a SMAC mimetic, effectivity binds to and inhibits multiple IAPs (i.e. XIAP, c-IAP).
More Information Supplier Page
Sepantronium bromide (YM155) is a small-molecule proapoptotic agent with potential antineoplastic activity.
More Information Supplier Page
Sepantronium bromide (YM155) is a small-molecule proapoptotic agent with potential antineoplastic activity.
More Information Supplier Page